Department of Health and Community Services, Government of Newfoundland and Labrador
St. John's, Newfoundland and Labrador, A1B 3X9, Canada
NCT Number: NCT03205475
This study will focus on examining the supports required to enable community Senior JASPER Trainers to support the training and development of junior interventionists throughout the province of Newfoundland and Labrador, Canada. The study will examine the training and supports delivered by Senior Trainers to help junior interventionists provide a targeted social communication intervention (JASPER: Joint Attention, Symbolic Play, Engagement, and Regulation) with children with autism spectrum disorder (ASD). Children's engagement, play, and social communication outcomes will be examined as well as the influence of junior interventionists' intervention implementation on children's outcomes. Further, the study will examine the supports required to help junior interventionists who demonstrate slower gains in implementation fidelity after the first three months of standard support. Interventionists who are slow to gain implementation fidelity will be randomized to either (a) enhanced feedback plus peer support or (b) enhanced feedback plus intensive refresher course.
Looking for future studies?
Notify Me24 month–97 month
All sexes
Interventional
Not applicable
St. John's, Newfoundland and Labrador, A1B 3X9, Canada
The proposed study is an adaptive intervention trial that will focus on tailoring supports for new JASPER interventionists. Coaching and training supports will be provided by Local Senior JASPER Trainers will support the development of new interventionists. Based on the interventionist's individual response to the coaching/training supports, a change in support may be provided at a priori time points including end of month 1 (training case) if at least 70% fidelity is not reached, and at end of month 4 (midpoint of first child cohort), at least 90% fidelity is not reached.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Alternates each week between live/tele-health coaching (coaching) or Video review and call (feedback)
Weekly coaching (live or telehealth)
Continue weekly coaching with senior trainer and add one week intensive refresher course
Continue weekly coaching with senior trainer and add weekly peer coaching from another interventionist in the region who is at high fidelity
Receive video feedback and calls only
Time frame: Entry, 1 month, 4 months, and 7 month exit
Quantitative ratings of the interventionists' quality and accurate use of JASPER intervention strategies.
Time frame: Entry for cohort two (month 2), half way (month 4), and exit (month 7)
Time the child spends jointly engaged in interactions with the interventionist
Time frame: Entry for cohort two (month 2), half way (month 4), and exit (month 7)
Rated during the child's interactions with the interventionist and during independent assessment, this includes the child's spontaneous play types by play level and child's spontaneous spoken and nonverbal communication skills to request and to share
Government of Newfoundland and Labrador
Other Gov
JASPER Implementation Cascade: Newfoundland and Labrador
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07644468
Autism Spectrum Disorder, Behavior
Taipei, Taiwan
View Trial DetailsNCT05081245
Autism Spectrum Disorder, Autistic Disorder
Dothan, Alabama, United States
View Trial DetailsNCT06453629
Autism Spectrum Disorder, Behavior
Carlsbad, California, United States
View Trial DetailsNCT04936048
Autism, Autism Spectrum Disorder
Vienna, Austria
View Trial Details